Journal of Neural Transmission

, Volume 113, Issue 10, pp 1463–1468 | Cite as

Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?

  • M. W. Riepe
  • J. Kassubek
  • F. Tracik
  • G. Ebersbach
Article

Summary.

The frequency and pattern of cognitive deficits in Parkinson’s disease (PD) is under discussion. We assessed 157 consecutive subjects with PD (66.4 ± 8.9 years (mean ± standard deviation); average duration of disease 3.5 ± 1.3 years; average Hoehn and Yahr stage 2.4 ± 0.9) diagnosed in centers specialized for the diagnosis and treatment of PD with brief tests for memory (Memory Impairment Screen), attention (Letter Sorting Test) and semantic fluency (category animals). Impaired memory was observed in about one half of the subjects regardless of severity of disease as assessed by staging according to Hoehn and Yahr. With greater severity, free recall was impaired and subjects required the cues to recall the items. Performance in the Letter Sorting Test and the semantic fluency task declined with increasing Hoehn and Yahr stage, also. We conclude that cognitive deficits are frequent in PD. Further analyses reveal that even in selected screening tests (e.g. semantic fluency) a significant impairment with increasing disease severity (Hoehn and Yahr stage) as opposed to disease duration alone can be demonstrated.

Keywords: Cognition, screening, memory, attention, semantic fluency, severity. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azuma, T, Cruz, RF, Bayles, KA, Tomoeda, CK, Montgomery, EB,Jr 2003A longitudinal study of neuropsychological change in individuals with Parkinson’s diseaseInt J Geriatr Psychiatry1811151120PubMedCrossRefGoogle Scholar
  2. Baddeley, A 1992Working memoryScience255556559PubMedGoogle Scholar
  3. Baddeley, A 2000The episodic buffer: a new component of working memory?Trends Cogn Sci4417423PubMedCrossRefGoogle Scholar
  4. Beinhoff, U, Hilbert, V, Bittner, D, Gron, G, Riepe, MW 2005Screening for cognitive impairment: a triage for outpatient careDement Geriatr Cogn Disord20278285PubMedCrossRefGoogle Scholar
  5. Bosboom, JL, Stoffers, D, Wolters, EC 2004Cognitive dysfunction and dementia in Parkinson’s diseaseJ Neural Transm11113031315PubMedCrossRefGoogle Scholar
  6. Breen, EK 1993Recall and recognition memory in Parkinson’s diseaseCortex2991102PubMedGoogle Scholar
  7. Brown, RG, Marsden, CD 1984How common is dementia in Parkinson’s disease?Lancet212621265PubMedCrossRefGoogle Scholar
  8. Bublak, P, Muller, U, Gron, G, Reuter, M, von Cramon, DY 2002Manipulation of working memory information is impaired in Parkinson’s disease and related to working memory capacityNeuropsychology16577590PubMedCrossRefGoogle Scholar
  9. Buschke, H, Kuslansky, G, Katz, M, Stewart, WF, Sliwinski, MJ, Eckholdt, HM, Lipton, RB 1999Screening for dementia with the memory impairment screenNeurology52231238PubMedGoogle Scholar
  10. Desgranges, B, Baron, JC, Eustache, F 1998The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areasNeuroimage8198213PubMedCrossRefGoogle Scholar
  11. Emre, M 2003What causes mental dysfunction in Parkinson’s disease?Mov Disord18S63S71PubMedCrossRefGoogle Scholar
  12. Emre, M, Aarsland, D, Albanese, A, Byrne, EJ, Deuschl, G, De Deyn, PP, Durif, F, Kulisevsky, J, van Laar, T, Lees, A, Poewe, W, Robillard, A, Rosa, MM, Wolters, E, Quarg, P, Tekin, S, Lane, R 2004Rivastigmine for dementia associated with Parkinson’s diseaseN Engl J Med35125092518PubMedCrossRefGoogle Scholar
  13. Erkinjuntti, T, Ostbye, T, Steenhuis, R, Hachinski, V 1997The effect of different diagnostic criteria on the prevalence of dementiaN Engl J Med33716671674PubMedCrossRefGoogle Scholar
  14. Goldman, WP, Baty, JD, Buckles, VD, Sahrmann, S, Morris, JC 1998Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementiaArch Neurol55674680PubMedCrossRefGoogle Scholar
  15. Graceffa, AM, Carlesimo, GA, Peppe, A, Caltagirone, C 1999Verbal working memory deficit in Parkinson’s disease subjectsEur Neurol429094PubMedCrossRefGoogle Scholar
  16. Green, J, McDonald, WM, Vitek, JL, Evatt, M, Freeman, A, Haber, M, Bakay, RA, Triche, S, Sirockman, B, DeLong, MR 2002Cognitive impairments in advanced PD without dementiaNeurology5913201324PubMedGoogle Scholar
  17. Henry, JD, Crawford, JR 2004Verbal fluency deficits in Parkinson’s disease: a meta-analysisJ Int Neuropsychol Soc10608622PubMedCrossRefGoogle Scholar
  18. Jacobs, DM, Marder, K, Cote, LJ, Sano, M, Stern, Y, Mayeux, R 1995Neuropsychological characteristics of preclinical dementia in Parkinson’s diseaseNeurology4516911696PubMedGoogle Scholar
  19. Leopold, NA, Borson, AJ 1997An alphabetical ‘WORLD’. A new version of an old testNeurology4915211524PubMedGoogle Scholar
  20. Levy, G, Jacobs, DM, Tang, MX, Cote, LJ, Louis, ED, Alfaro, B, Mejia, H, Stern, Y, Marder, K 2002Memory and executive function impairment predict dementia in Parkinson’s diseaseMov Disord1712211226PubMedCrossRefGoogle Scholar
  21. Lewis, SJ, Dove, A, Robbins, TW, Barker, RA, Owen, AM 2003Cognitive impairments in early Parkinson’s disease are accompanied by reductions in activity in frontostriatal neural circuitryJ Neurosci2363516356PubMedGoogle Scholar
  22. Lezak, M 1995Neuropsychological assessmentOxford University PressNew York, OxfordGoogle Scholar
  23. Mayeux, R, Stern, Y, Rosenstein, R, Marder, K, Hauser, A, Cote, L, Fahn, S 1988An estimate of the prevalence of dementia in idiopathic Parkinson’s diseaseArch Neurol45260262PubMedGoogle Scholar
  24. Riepe, MW, Riss, S, Bittner, D, Huber, R 2004Screening for cognitive impairment in patients with acute strokeDement Geriatr Cogn Disord174953PubMedCrossRefGoogle Scholar
  25. Weintraub, D, Moberg, PJ, Culbertson, WC, Duda, JE, Stern, MB 2004Evidence for impaired encoding and retrieval memory profiles in Parkinson diseaseCogn Behav Neurol17195200PubMedGoogle Scholar
  26. Werber, EA, Rabey, JM 2001The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson’s disease and dementiaJ Neural Transm10813191325PubMedCrossRefGoogle Scholar
  27. Zgaljardic, DJ, Foldi, NS, Borod, JC 2004Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributionsJ Neural Transm11112871301PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • M. W. Riepe
    • 1
  • J. Kassubek
    • 2
  • F. Tracik
    • 4
  • G. Ebersbach
    • 3
  1. 1.Department of PsychiatryCharité UniversitätsmedizinBerlinGermany
  2. 2.Department of NeurologyUniversity of UlmBeelitzGermany
  3. 3.Movement Disorder Clinic, Beelitz HeilstättenBeelitzGermany
  4. 4.Clinical Research and DevelopmentNovartisGermany

Personalised recommendations